249A — Human Adjust Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Human Adjust Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | JAS | JAS |
Status: | Final | Final |
Revenue | ||
Total Revenue | 1,374 | 1,953 |
Cost of Revenue | ||
Gross Profit | 374 | 659 |
Selling / General / Administrative Expenses | ||
Unusual Expense / Income | ||
Other Operating Expenses | ||
Total Operating Expenses | 1,448 | 1,900 |
Operating Profit | -73.2 | 52.8 |
Gain / Loss on Sale of Assets | ||
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | -54.8 | 45 |
Provision for Income Taxes | ||
Net Income After Taxes | -34.9 | 27.8 |
Net Income Before Extraordinary Items | ||
Net Income | -34.9 | 27.8 |
Adjustments to Net Income | ||
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -34.9 | 27.8 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -91.8 | 136 |
Dividends per Share |